<?xml version="1.0" encoding="UTF-8"?>
<!-- このサイトマップは、2026年11月20日の4:37 PMに、WordPress 用のオリジナル SEO プラグイン All in One SEO v5.0.5.1により動的生成されました。 -->

<?xml-stylesheet type="text/xsl" href="https://infojuggle.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>InfoJuggle</title>
		<link><![CDATA[https://infojuggle.com]]></link>
		<description><![CDATA[InfoJuggle]]></description>
		<lastBuildDate><![CDATA[Fri, 20 Nov 2026 05:41:00 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://infojuggle.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://infojuggle.com/jgc-1963-offshore-energy-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/jgc-1963-offshore-energy-research/]]></link>
			<title>日揮HD(1963)2Q｜LNGカナダ受注と妥当レンジ</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 05:41:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/modec-6269-offshore-energy-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/modec-6269-offshore-energy-research/]]></link>
			<title>三井海洋開発(6269)3Q｜上方修正と受注空白の妥当レンジ</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 05:29:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/nabtesco-6268-machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/nabtesco-6268-machinery-research/]]></link>
			<title>ナブテスコ(6268)3Q決算分析｜急落後の妥当レンジ</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 15:29:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/hioki-6866-machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/hioki-6866-machinery-research/]]></link>
			<title>日置電機（6866）｜受注4割増でも株価3割安の理由</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 15:21:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/minebea-mitsumi-6479-machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/minebea-mitsumi-6479-machinery-research/]]></link>
			<title>ミネベアミツミ（6479）｜最高益でも株価下落の理由</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 15:11:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/omron-6645-machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/omron-6645-machinery-research/]]></link>
			<title>オムロン（6645）｜2度の上方修正でも株価下落</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 15:02:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/renesas-6723-semiconductor-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/renesas-6723-semiconductor-analysis-2026/]]></link>
			<title>ルネサス（6723）｜3Q上振れでも株価半値の理由</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 14:04:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/kokusai-electric-6525-semiconductor-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/kokusai-electric-6525-semiconductor-analysis-2026/]]></link>
			<title>KOKUSAI（6525）｜受注最高でも株価半値の理由</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 13:57:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/screen-holdings-7735-semiconductor-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/screen-holdings-7735-semiconductor-analysis-2026/]]></link>
			<title>SCREEN HD（7735）｜上期増益でも株価6割安の理由</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 13:32:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/chiome-bioscience-4583-antibody-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/chiome-bioscience-4583-antibody-rnpv-analysis/]]></link>
			<title>カイオム(4583)抗体導出待ちの資金とrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 10:04:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/cyfuse-biomedical-4892-3d-bioprinting-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/cyfuse-biomedical-4892-3d-bioprinting-rnpv-analysis/]]></link>
			<title>サイフューズ(4892)骨軟骨治験開始とrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 06:12:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/heartseed-219a-ips-cardiomyocyte-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/heartseed-219a-ips-cardiomyocyte-rnpv-analysis/]]></link>
			<title>ハートシード(219A)先駆け指定と申請前のrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 06:07:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/healios-4593-pipeline-analysis-ards-ipsc-nk/]]></guid>
			<link><![CDATA[https://infojuggle.com/healios-4593-pipeline-analysis-ards-ipsc-nk/]]></link>
			<title>ヘリオス(4593)ARDS申請前の資金とrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 06:03:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/noile-immune-4893-prime-cart-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/noile-immune-4893-prime-cart-rnpv-analysis/]]></link>
			<title>ノイルイミューン(4893)NIB103治験中のrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:58:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/kringle-pharma-4884-hgf-sci-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/kringle-pharma-4884-hgf-sci-rnpv-analysis/]]></link>
			<title>クリングル(4884)HGF声帯瘢痕Ph3前のrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:52:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/chordia-therapeutics-190a-clk-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/chordia-therapeutics-190a-clk-rnpv-analysis/]]></link>
			<title>コーディア(190A)CLK阻害薬のrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:47:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/delta-fly-pharma-4598-rnpv-pipeline-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/delta-fly-pharma-4598-rnpv-pipeline-analysis/]]></link>
			<title>デルタフライ(4598)ASH・FDA協議前のrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:37:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/prismbiolab-206a-pipeline-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/prismbiolab-206a-pipeline-research/]]></link>
			<title>PRISM(206A)E7386判定前のrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:31:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/perseus-proteomics-4882-tfr1-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/perseus-proteomics-4882-tfr1-rnpv-analysis/]]></link>
			<title>ペルセウス(4882)TfR1抗体ASH発表前のrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:24:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/tims-4891-biopharma-pipeline-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/tims-4891-biopharma-pipeline-analysis/]]></link>
			<title>ティムス(4891)脳梗塞新薬ORIONとrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:16:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/canbas-4575-cbp501-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/canbas-4575-cbp501-rnpv-analysis/]]></link>
			<title>キャンバス(4575)CBP501欧州Ph3承認とrNPV再試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 05:05:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/jt-2914-russia-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/jt-2914-russia-research/]]></link>
			<title>JT(2914)ロシア一時管理後の妥当株価を試算</title>
			<pubDate><![CDATA[Thu, 19 Nov 2026 01:48:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/biopharma-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/biopharma-research/]]></link>
			<title>バイオ医薬品 パイプライン調査レポート一覧</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 22:54:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/machinery-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/machinery-research/]]></link>
			<title>機械株 調査レポート一覧</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 22:39:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/financial-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/financial-research/]]></link>
			<title>金融株　調査レポート一覧</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 22:39:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/data-breach-causes-countermeasures-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/data-breach-causes-countermeasures-2026/]]></link>
			<title>情報漏洩2026年総まとめ｜事例・対策・処方箋</title>
			<pubDate><![CDATA[Wed, 18 Nov 2026 16:21:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/bank-of-innovation-4393-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/bank-of-innovation-4393-growth-analysis/]]></link>
			<title>バンクオブイノベ4393｜新作RPGの進捗と通期決算</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 11:47:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/cuorips-4894-ips-cardiomyocyte-rnpv-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/cuorips-4894-ips-cardiomyocyte-rnpv-analysis/]]></link>
			<title>クオリプス(4894) 3例移植と2Q決算でrNPV再評価</title>
			<pubDate><![CDATA[Sun, 15 Nov 2026 11:25:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/freakout-6094-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/freakout-6094-growth-analysis/]]></link>
			<title>フリークアウト6094｜通期決算と新中計を分析</title>
			<pubDate><![CDATA[Sat, 14 Nov 2026 22:11:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/physical-ai-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/physical-ai-research/]]></link>
			<title>フィジカルAI 関連銘柄 特集記事一覧</title>
			<pubDate><![CDATA[Sat, 14 Nov 2026 13:43:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/physical-ai-earnings-rally-japan-stocks/]]></guid>
			<link><![CDATA[https://infojuggle.com/physical-ai-earnings-rally-japan-stocks/]]></link>
			<title>フィジカルAI業績相場で伸びる株・伸びにくい株12選</title>
			<pubDate><![CDATA[Sat, 14 Nov 2026 13:43:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/nomura-micro-science-6254-semiconductor-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/nomura-micro-science-6254-semiconductor-analysis-2026/]]></link>
			<title>野村マイクロ6254決算分析｜受注3倍増も2Q赤字</title>
			<pubDate><![CDATA[Sat, 14 Nov 2026 10:01:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/rakuten-4755-infocom-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/rakuten-4755-infocom-research/]]></link>
			<title>楽天グループ4755｜3Q最終赤字627億円と通期黒字化の壁</title>
			<pubDate><![CDATA[Sat, 14 Nov 2026 09:25:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/nankai-chemical-4040-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/nankai-chemical-4040-research/]]></link>
			<title>南海化学4040｜中間営業益73%増の中身と割安度</title>
			<pubDate><![CDATA[Sat, 14 Nov 2026 02:56:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/mufg-8306-financial-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/mufg-8306-financial-research/]]></link>
			<title>三菱UFJ8306｜中間純利益1.6兆円と目標2.8兆円の中身</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 22:57:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/mizuho-8411-financial-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/mizuho-8411-financial-research/]]></link>
			<title>みずほFG8411｜2度目の上方修正 純利益1.6兆円の中身</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 22:39:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/smfg-8316-financial-research/]]></guid>
			<link><![CDATA[https://infojuggle.com/smfg-8316-financial-research/]]></link>
			<title>三井住友FG8316｜中間決算で純利益1.9兆円へ上方修正</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 21:58:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/shanon-3976-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/shanon-3976-growth-analysis/]]></link>
			<title>シャノン(3976)3Q分析｜初配当と通期予想の保守性</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 21:41:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/aimechatec-6227-semiconductor-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/aimechatec-6227-semiconductor-analysis/]]></link>
			<title>AIメカテック(6227)1Q分析｜受注残583億円と顧客集中</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 21:31:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/f-code-9211-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/f-code-9211-growth-analysis/]]></link>
			<title>エフ・コード(9211)3Q分析｜売上超過とのれんの重さ</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 21:25:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/seikoh-giken-6834-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/seikoh-giken-6834-growth-analysis/]]></link>
			<title>精工技研(6834)中間分析｜光コネクタ需要と下期計画</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 21:20:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/torex-6616-semiconductor-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/torex-6616-semiconductor-analysis/]]></link>
			<title>トレックス(6616)中間分析｜上方修正と下期計画の落差</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 17:18:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/nfk-6494-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/nfk-6494-growth-analysis/]]></link>
			<title>NFKホールディングス(6494)中間分析｜M&#038;Aで増収の実像</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 17:09:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/mipox-5381-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/mipox-5381-growth-analysis/]]></link>
			<title>マイポックス(5381)中間決算｜上方修正と現金化の課題</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 17:02:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/stamen-4019-growth-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/stamen-4019-growth-analysis/]]></link>
			<title>スタメン(4019)3Q分析｜最高益と売上計画未達リスク</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 16:53:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/gni-group-2160-pipeline-rnpv-analysis-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/gni-group-2160-pipeline-rnpv-analysis-2026/]]></link>
			<title>GNI2160決算｜F351判断は年末〜Q1、借入816億</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 11:34:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/accrete-4395-special-investigation-report-2026/]]></guid>
			<link><![CDATA[https://infojuggle.com/accrete-4395-special-investigation-report-2026/]]></link>
			<title>アクリート中間決算｜監査人が結論不表明、第三者委へ</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 10:54:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/jdsc-4418-equity-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/jdsc-4418-equity-analysis/]]></link>
			<title>JDSC4418決算｜AI事業1Q+88%と新中計を検証</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 10:44:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/tier-iv-593a-ipo-analysis/]]></guid>
			<link><![CDATA[https://infojuggle.com/tier-iv-593a-ipo-analysis/]]></link>
			<title>ティアフォー593A決算｜台数129台と27年予想を検証</title>
			<pubDate><![CDATA[Fri, 13 Nov 2026 10:36:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://infojuggle.com/]]></guid>
			<link><![CDATA[https://infojuggle.com/]]></link>
			<title>InfoJuggle　インフォジャグル</title>
			<pubDate><![CDATA[Wed, 11 Nov 2026 16:02:49 +0000]]></pubDate>
		</item>
				</channel>
</rss>
